The estimated Net Worth of Timothy J. Arens is at least $5.23 millió dollars as of 16 August 2024. Mr. Arens owns over 18,447 units of Surmodics stock worth over $3,691,072 and over the last 14 years he sold SRDX stock worth over $723,726. In addition, he makes $816,555 as Chief Financial Officer és Vice President - Finance at Surmodics.
Timothy has made over 10 trades of the Surmodics stock since 2014, according to the Form 4 filled with the SEC. Most recently he exercised 18,447 units of SRDX stock worth $612,440 on 16 August 2024.
The largest trade he's ever made was exercising 28,913 units of Surmodics stock on 1 August 2016 worth over $395,241. On average, Timothy trades about 3,448 units every 89 days since 2010. As of 16 August 2024 he still owns at least 94,088 units of Surmodics stock.
You can see the complete history of Mr. Arens stock trades at the bottom of the page.
Timothy J. Arens serves as Chief Financial Officer, Vice President - Finance of the Company. n Vitro Diagnostics in October 2010. He was promoted to Vice President of Finance and Interim Chief Financial Officer in August 2011 and in February 2013 became Vice President Corporate Development and Strategy. In May 2018, Mr. Arens was named interim Vice President of Finance and Chief Financial Officer for a second time and in February 2019 he was named Vice President of Finance and Chief Financial Officer. Prior to joining Surmodics, Mr. Arens was employed at St. Jude Medical, Inc., a medical technology company, from 2003 to 2007, in positions of increasing responsibility related to business development and strategic planning functions.
As the Chief Financial Officer és Vice President - Finance of Surmodics, the total compensation of Timothy Arens at Surmodics is $816,555. There are 6 executives at Surmodics getting paid more, with Gary Maharaj having the highest compensation of $2,343,630.
Timothy Arens is 52, he's been the Chief Financial Officer és Vice President - Finance of Surmodics since 2019. There are 17 older and 3 younger executives at Surmodics. The oldest executive at Surmodics, Inc. is David Dantzker, 76, who is the Independent Director.
Timothy's mailing address filed with the SEC is 9924, West 74th Street, Eden Prairie, Hennepin County, Minnesota, 55344, United States of America.
Over the last 21 years, insiders at Surmodics have traded over $26,204,565 worth of Surmodics stock and bought 19,725 units worth $436,251 . The most active insiders traders include Jeffrey C Smith, Gary R Maharaj és Value Lp Starboard Value Gp.... On average, Surmodics executives and independent directors trade stock every 34 days with the average trade being worth of $415,014. The most recent stock trade was executed by Joseph J. Stich on 21 August 2024, trading 21,285 units of SRDX stock currently worth $706,662.
surmodics partners with the world's leading and emerging medical device, diagnostic and life sciences companies to develop and commercialize innovative products designed to improve lives by enabling the detection and treatment of disease. following two recent acquisitions, the company is transforming its medical device business from being a provider of coating technologies, to offering whole-product solutions. throughout its transformation, surmodics’ mission remains: to improve the detection and treatment of disease by using our technology to provide solutions to difficult medical device and diagnostic challenges.
Surmodics executives and other stock owners filed with the SEC include: